Rombo syndrome
Rombo syndrome is a rare genetic disorder characterized by distinctive skin abnormalities, a predisposition to certain types of skin cancer, and other systemic manifestations. The syndrome was first described in the medical literature in the early 1980s.
Presentation[edit | edit source]
Individuals with Rombo syndrome typically present with a variety of skin abnormalities that become apparent in early childhood. These include:
- Atrophoderma vermiculatum: A condition characterized by pitted scars on the face.
- Telangiectasia: Small, dilated blood vessels near the surface of the skin.
- Hypotrichosis: Reduced hair growth, particularly affecting the scalp, eyebrows, and eyelashes.
- Acral erythema: Redness of the skin, particularly on the hands and feet.
Genetics[edit | edit source]
Rombo syndrome is inherited in an autosomal dominant pattern, meaning that a single copy of the altered gene in each cell is sufficient to cause the disorder. The specific gene or genes associated with Rombo syndrome have not yet been identified.
Diagnosis[edit | edit source]
The diagnosis of Rombo syndrome is primarily clinical, based on the characteristic skin findings and family history. Genetic testing may be used to rule out other conditions with similar presentations.
Management[edit | edit source]
There is no cure for Rombo syndrome, and treatment is primarily supportive. Management strategies may include:
- Regular dermatological evaluations to monitor for skin cancer.
- Use of sunscreens and protective clothing to minimize sun exposure.
- Cosmetic treatments for skin lesions, such as laser therapy.
Prognosis[edit | edit source]
The prognosis for individuals with Rombo syndrome varies. While the skin abnormalities are typically benign, there is an increased risk of developing basal cell carcinoma and other skin cancers, which requires ongoing surveillance and management.
Related Pages[edit | edit source]
- Atrophoderma vermiculatum
- Telangiectasia
- Hypotrichosis
- Acral erythema
- Basal cell carcinoma
- Autosomal dominant
Categories[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD